Arlene Morris
CIK 1362520 · CEO · last filed 2026-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$320.7K
Companies
12
Total Filings
82
Lifetime Open-Market Net
-$16.32M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VRDN | Director | — | $19.51 | — | $0 | 7 | 2026-07-02 |
| EWTX | Director | — | $40.35 | — | $0 | 4 | 2026-06-17 |
| COGT | Director | — | $40.67 | — | $0 | 6 | 2026-06-11 |
| PTN | Director | 41,580 | $7.68 | $319.3K | $28.7K | 16 | 2025-12-11 |
| VIVEVE MEDICAL, INC. (VIVE) Delisted | Director | 2 | $0.00 | $0 | $0 | 13 | 2023-01-05 |
| Cogent Biosciences, Inc. (UMRX) Delisted | Director | — | — | — | $0 | 2 | 2020-06-11 |
| Viridian Therapeutics, Inc.\DE (MGEN) Delisted | Director | — | — | — | $0 | 3 | 2020-05-22 |
| Dimension Therapeutics, Inc. (DMTX) Delisted | Director | — | — | — | $0 | 3 | 2017-11-07 |
| VIVEVE MEDICAL, INC. (TCON) Delisted | Director | — | $0.03 | — | $0 | 1 | 2016-05-20 |
| ALBIREO PHARMA, INC. (BIOD) Delisted | Director | — | — | — | $0 | 2 | 2016-03-08 |
| MNOV | Director | 1,000 | $1.33 | $1.3K | -$28.9K | 7 | 2013-05-23 |
| AFFYMAX INC (AFFY) Delisted | CEO | 75,000 | — | — | -$16.32M | 18 | 2010-09-24 |
Recent Filings · Page 2 of 9
82 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-12 | EWTX | Grant (A) | — | $0 | EDGAR |
| 2024-05-07 | EWTX | Grant (A) | — | $0 | EDGAR |
| 2023-06-22 | PTN | Grant (A) | +10,000 | $0 | EDGAR |
| 2023-06-16 | VRDN | Grant (A) | — | $0 | EDGAR |
| 2023-06-08 | COGT | Grant (A) | — | $0 | EDGAR |
| 2023-01-05 | VIVEVE MEDICAL, INC. (VIVE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-24 | PTN | Grant (A) | +73,000 | $0 | EDGAR |
| 2022-06-10 | VRDN | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | COGT | Grant (A) | — | $0 | EDGAR |
| 2022-01-06 | VIVEVE MEDICAL, INC. (VIVE) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.